Phospholipase D3 regulates TFEB/TFE3 metabolism to maintain lysosomal homeostasis
Wang, Y.; Rieschick, P.; Fernandez, W. R.; Appelbaum, N.; Tapia, C. C.; Kozunda, A.; Schrag, M.
Show abstract
Phospholipase D3 (PLD3) is a lysosomal protein in neurons and is linked to an Alzheimers disease (AD) risk through coding variants. Its role in lysosomal abnormalities observed in AD remains unclear. We conducted a comprehensive study integrating transcriptomic, proteomic, and cell biology approaches to investigate PLD3s role in lysosome function in neurons. PLD3 undergoes aberrant ubiquitination in AD brain tissue, leading to altered protein abundance and subcellular location. We assessed the lysosomal proteome in SH-SY5Y cells with PLD3 knockout and found PLD3-/- cells had higher levels of proteins related to lysosomal biogenesis, endocytosis, and calcium signaling. Loss of PLD3 caused an enlargement in neuronal lysosome size, increased endocytic activity and a decline in lysosomal clearance of aggregated human {beta}-amyloid or -synuclein, despite increased expression level and activity of cathepsin B. PLD3-deficiency increase the level and transcriptional activity of transcription factor EB (TFEB) and transcription factor binding to IGHM enhancer 3 (TFE3), suggesting a role for PLD3 in regulating lysosomal biogenesis. In summary, we found that PLD3 is required to maintain neuronal lysosomal function.
Matching journals
The top 7 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- PTP1B inhibition promotes microglial phagocytosis in Alzheimer's disease models by enhancing SYK signaling 97%
- Protein mishandling and impaired lysosomal proteolysis generated through calcium dysregulation in Alzheimer's disease 96%
- The inhibition of LSD1 via sequestration contributes to tau-mediated neurodegeneration 96%
Similar papers in this journal
- Aβ-driven nuclear pore complex dysfunction alters activation of necroptosis proteins in a mouse model of Alzheimer's Disease 95%
- Downregulation of Dickkopf-3, a Wnt antagonist elevated in Alzheimer's disease, restores synapse integrity and memory in a disease mouse model 95%
- APOE Expression and Secretion are Modulated by Mitochondrial Dysfunction 95%
Similar papers in this journal
- β-Amyloid Induces Microglial Expression of GPC4 and APOE Leading to Increased Neuronal Tau Pathology and Toxicity 96%
- APOE Christchurch enhances a disease-associated microglial response to plaque but suppresses response to tau pathology 96%
- LRRK2 Kinase Activity Regulates Parkinson's Disease-Relevant Lipids at the Lysosome 95%
Similar papers in this journal
- Lysosomal dysfunction in Down Syndrome and Alzheimer mouse models is caused by selective v-ATPase inhibition by Tyr682 phosphorylated APP βCTF 96%
- Parkinsons VPS35 mutation induces LRRK2 mediated lysosomal association of RILPL1 and TMEM55B 95%
- Astrocytic TDP-43 dysregulation impairs memory by modulating antiviral pathways and interferon-inducible chemokines 95%
Similar papers in this journal
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.